Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01799850 · ClinicalTrials.gov registry record · Phase 4
The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle
A Phase 4 study, sponsored by East Tennessee State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT01799850 is a Phase 4 study that has completed, run by East Tennessee State University. The registered enrollment target is 12 participants.
The verdict
NCT01799850, a Phase 4 study, has completed, sponsored by East Tennessee State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
Subjects with type 2 diabetes will be treated with Actos or placebo for eight weeks and needle biopsies of muscle will quantify changes in any of seven different glucose transport proteins in muscle.
Interventions
- DRUG placebo
- DRUG Pioglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2002-03 |
| Est. Completion | 2004-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01799850
The ClinicalTrials.gov registry entry for NCT01799850 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is East Tennessee State University, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01799850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01799850 about?
NCT01799850 is a clinical study titled "The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle". Subjects with type 2 diabetes will be treated with Actos or placebo for eight weeks and needle biopsies of muscle will quantify changes in any of seven different glucose transport proteins in muscle.
What is the current status of trial NCT01799850?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2002-03. Estimated completion is 2004-03.
What interventions are being tested in trial NCT01799850?
The interventions under investigation include: placebo (DRUG), Pioglitazone (DRUG).
Who is sponsoring clinical trial NCT01799850?
This trial is sponsored by East Tennessee State University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.